Roche’s Ocrevus has been approved for use in Europe to treat adults with relapsing multiple sclerosis (RMS) and early primary progressive multiple sclerosis (PPMS).
Related Biotechnology, Pharmaceutical and Healthcare News
Biotechnology Business Alliances
Astrazeneca
Bioethics
Boehringer
Clinical Research Organization
Collaborations
GSK
Johnson & Johnson
Lilly
Merck
Mergers and Acquisitions
Nexium
Novartis
Pfizer
Roche
Sanofi
...
Spinal Cord Disorders The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine.
An accident that damages the verte...